In August 2019, Jianping Jia’s team of Xuanwu Hospital published an online article entitled “Dementia in China: epidemiology, clinical management, and research advances” in the top international medical journal “The Lancet Neurology” (5 years IF: 30.542). Through more than 20 years of in-depth research on people with dementia, the research team summarized the current situation of dementia patients in China from five aspects: epidemiology, health economics, disease diagnosis, clinical management and clinical trials. It is the first internationally to put forward the severe problems facing dementia in china and the intervention plans and prevention and control strategies that should be adopted. Longfei Jia , from the Department of Neurology, Xuanwu Hospital of Capital Medical University, is the first author, and Professor Jianping Jia is the corresponding author.
China has gradually entered an aging society, with senile diseases increasing, especially dementia patients. It is estimated that there are more than 10 million senile dementia patients, 31 million patients with mild cognitive impairment, and 9.5 million post-stroke dementia patients, totaling more than 50 million people with dementia and cognitive impairment. Faced with such a large population of patients with dementia and cognitive impairment, on the one hand, we should realize that the current corresponding medical services and care cannot meet the needs of patients; on the other hand, we need to reflect on the reasons for the continuous increase in the number of patients with dementia and cognitive impairment. . It also proposed effective prevention and control strategies.
The prevention and control of dementia and cognitive impairment has become a major social problem that needs to be solved urgently in our country. The author puts forward the following five suggestions for the current status of dementia in China:
The prevention and control of dementia and cognitive impairment in China has become a major social problem that needs to be solved urgently. The author puts forward the following five suggestions for the current status of dementia in China:
(1) A national monitoring system should be established to analyze and evaluate the incidence, prevalence, risk and protective factors of dementia in the elderly population across the country, and establish national primary and secondary dementia prevention and control strategies based on these basic data.
(2) Develop and implement a national-level dementia specialist training plan, set up memory clinics in general hospitals, and build a professional team and system for preventing and treating dementia in China.
(3) Improve the facilities and level of care services for dementia in China, and form a nursing system with Chinese characteristics by training professional nursing staff and supporting measures to reduce the physical and mental burden of nursing staff.
(4) Explore the anti-dementia prescriptions in the treasure house of traditional Chinese medicine, and verify its effectiveness through internationally recognized randomized double-blind controlled clinical trials.
(5) Build an open and transparent clinical trial platform to widely attract clinical trials of anti-dementia drugs at domestic and foreign, and adopt uniform standards and strictly control the quality of trials to ensure that accurate and effective anti-dementia drugs are introduced to the market.
This article was published in an internationally renowned medical journal. It provides an in-depth analysis of the current situation of dementia and cognitive impairment in China from a comprehensive and unique perspective. It is the first to propose intervention programs and prevention and control strategies for dementia in China to reduce the prevalence and incidence of dementia in China. Provides a theoretical basis, which has a milestone significance for the effective prevention and control of dementia and cognitive impairment.
This subject is funded by the National Natural Science Foundation of China Key Project (81530036), Major Scientific Research Instrument Development Project (31627803) and other projects.